<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Korean J Hepatol via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Korean J Hepatol' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Korean+J+Hepatol&t=Korean+J+Hepatol&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 31 Oct 2010 10:09:52 +0100</lastBuildDate>
        <item>
            <title>New treatments for chronic hepatitis C.</title>
            <link>http://www.medworm.com/index.php?rid=4053671&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924208%26dopt%3DAbstract</link>
            <description>Authors: Jang JY, Chung RT
    Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of care (SOC) is peginterferon alfa-2a/-2b with ribavirin for 48 weeks or 24 weeks in patients infected with HCV genotype 1 or 2/3, respectively. The treatment duration can be individualized based on the baseline viral load and the speed of the virologic response during treatment. However, current therapies are associated with side effects, complications, and poor patient tolerability. Therefore, there is an urgent need to identify better strategies for treating this disease. An improved sustained virologic response (SVR) can be achieved with new HCV-specific inhibitors against NS3/4A and NS5B polymerases. Recent trials have found SVR rates in patients with HCV gen...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053671</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053671</guid>        </item>
        <item>
            <title>Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis.</title>
            <link>http://www.medworm.com/index.php?rid=4053670&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924209%26dopt%3DAbstract</link>
            <description>Authors: Kim JW
    
    PMID: 20924209 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053670</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053670</guid>        </item>
        <item>
            <title>Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.</title>
            <link>http://www.medworm.com/index.php?rid=4053669&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924210%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These data suggest that adenovirus-mediated inhibition of HIF-1α inhibits the invasion, tube formation, and cell growth in HUVECs and HCC cells.
    PMID: 20924210 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053669</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053669</guid>        </item>
        <item>
            <title>Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.</title>
            <link>http://www.medworm.com/index.php?rid=4053668&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924211%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The role of prohepcidin may differ in different human liver diseases. In the setting of CH-C, both the serum prohepcidin and IL-6 levels were significantly elevated and were positively correlated with each other.
    PMID: 20924211 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053668</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053668</guid>        </item>
        <item>
            <title>Factors influencing the severity of acute viral hepatitis A.</title>
            <link>http://www.medworm.com/index.php?rid=4053667&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924212%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: While most patients with acute hepatitis A have an uncomplicated clinical course, our data suggest that a more-severe clinical course is correlated with being older, significant alcohol intake, and chronic hepatitis-B-virus infection.
    PMID: 20924212 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053667</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053667</guid>        </item>
        <item>
            <title>Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis.</title>
            <link>http://www.medworm.com/index.php?rid=4053666&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924213%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The accuracy in predicting acute kidney injury and short-term mortality was higher for a serum cystatin C level of &amp;gt;1.23 mg/L than for the serum creatinine concentration in patients with cirrhosis.
    PMID: 20924213 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053666</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053666</guid>        </item>
        <item>
            <title>Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.</title>
            <link>http://www.medworm.com/index.php?rid=4053665&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924214%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Alcohol intake might not increase the risk of HCC in patients with HBV infection.
    PMID: 20924214 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053665</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053665</guid>        </item>
        <item>
            <title>Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study.</title>
            <link>http://www.medworm.com/index.php?rid=4053664&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924215%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: A 48-week dosing with clevudine 30 mg daily was superior to lamivudine 100 mg daily in suppressing HBV replication, with no emergence of viral breakthrough in patients with HBeAg positive chronic hepatits B.
    PMID: 20924215 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053664</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053664</guid>        </item>
        <item>
            <title>A case of concomitant Gilbert's syndrome and hereditary spherocytosis.</title>
            <link>http://www.medworm.com/index.php?rid=4053663&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924216%26dopt%3DAbstract</link>
            <description>We describe moderate hyperbilirubinemia in a 28-year-old man who suffered from gallstones and splenomegaly, with combined disorders of hereditary spherocytosis (HS) and Gilbert's syndrome (GS). Since it is difficult to diagnose HS in the absence of signs of anemia, we evaluated both the genetic mutation in the UGT1A1 gene and abnormalities in the erythrocyte membrane protein; the former was heterozygous for a UGT1A1 allele with three mutations and the latter was partially deficient in ankyrin expression. This is the first report of the concomitance of HS and GS with three heterozygous mutations [T-3279G, A (TA)7TAA, and G211A] in the UGT1A1 gene.
    PMID: 20924216 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053663</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053663</guid>        </item>
        <item>
            <title>Detection of distant metastasis to skeletal muscle by (18)F-FDG-PET in a case of intrahepatic cholangiocarcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=4053662&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924217%26dopt%3DAbstract</link>
            <description>Authors: Park SK, Kim YS, Kim SG, Jang JY, Moon JH, Lee MS, Kim BS, Koh ES, Park JM
    Intrahepatic cholangiocarcinoma is a rare malignancy that originates from the epithelial cells of the intrahepatic bile ducts. Intrahepatic cholangiocarcinoma can metastasize in lymphatic chains, including the hepatoduodenal ligament, and it often invades adjacent organs or metastasizes to other visceral organs such as the lungs, bones, adrenal glands, and brain. However, distant skeletal muscle metastasis is very rare. Moreover, a metastatic skeletal muscle tumor rarely shows specific symptoms, making it difficult to identify in a routine examination. A 45-year-old man with a chief complaint of right upper quadrant abdominal pain was admitted to our hospital. Abdominal ultrasound and computed tomograph...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053662</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053662</guid>        </item>
        <item>
            <title>Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases.</title>
            <link>http://www.medworm.com/index.php?rid=4053661&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924218%26dopt%3DAbstract</link>
            <description>We report three cases of severely cholestatic hepatitis A, who showed favorable responses to oral corticosteroids. Thirty milligram of prednisolone was initiated and tapered according to the responses. Rapid improvement was observed in all cases without side effects. We suggest that corticosteroid administration can be useful in hepatitis A patients with severe cholestasis who do not show improvement by conservative managements. Clinical trial will be needed to evaluate effectiveness of corticosteroids in these patients.
    PMID: 20924218 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053661</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053661</guid>        </item>
        <item>
            <title>Massive hepatic necrosis with large regenerative nodules.</title>
            <link>http://www.medworm.com/index.php?rid=4053660&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924219%26dopt%3DAbstract</link>
            <description>Authors: Kim H, Park YN
    
    PMID: 20924219 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053660</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053660</guid>        </item>
        <item>
            <title>Hepatic adrenal rest tumor mimicking hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=4053659&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924220%26dopt%3DAbstract</link>
            <description>Authors: Shin YM
    
    PMID: 20924220 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053659</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053659</guid>        </item>
        <item>
            <title>Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B.</title>
            <link>http://www.medworm.com/index.php?rid=4053658&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20924221%26dopt%3DAbstract</link>
            <description>Authors: Jang JW
    
    PMID: 20924221 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4053658</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4053658</guid>        </item>
        <item>
            <title>[Prognosis of Korean patients with primary biliary cirrhosis]</title>
            <link>http://www.medworm.com/index.php?rid=3867214&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606494%26dopt%3DAbstract</link>
            <description>Authors: Song BC
    
    PMID: 20606494 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867214</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867214</guid>        </item>
        <item>
            <title>[Pro-apoptotic function of hepatitis B virus X protein]</title>
            <link>http://www.medworm.com/index.php?rid=3867213&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606495%26dopt%3DAbstract</link>
            <description>Authors: Kim KH
    Infection of hepatitis B virus (HBV) is a main cause of liver diseases including hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Among the HBV-encoded proteins, the HBV X protein (HBx) has been suspected to be strongly involved in HBV-associated liver pathogenesis. HBx, a virally encoded multifunctional regulator, has been shown to induce apoptosis, anti-apoptosis, proliferation, and transformation of cells depending on the cell lines, model systems used, assay protocols, and research groups. Among the several activities of HBx, the pro-apoptotic function of HBx will be discussed in this review. Given that the disruption of apoptosis pathway by HBx contributes to the liver pathogenesis, a better understanding of the molecular interference in the cellular pro-ap...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867213</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867213</guid>        </item>
        <item>
            <title>[Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease]</title>
            <link>http://www.medworm.com/index.php?rid=3867212&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606496%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This study reveals that age, GGT, and albumin are clinical factors influencing LSM values. This reinforces the need to interpret LSM values in the context of a defined diagnosis, biochemical data, radiologic examination, and other clinical findings.
    PMID: 20606496 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867212</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867212</guid>        </item>
        <item>
            <title>[Clinical features of gas-forming liver abscesses: comparison between diabetic and nondiabetic patients]</title>
            <link>http://www.medworm.com/index.php?rid=3867211&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606497%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Gas-forming liver abscesses are not uncommon in cases of pyogenic liver abscesses and are associated with high morbidity and mortality rates. The clinical manifestations and complications do not differ significantly between DM and non-DM patients.
    PMID: 20606497 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867211</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867211</guid>        </item>
        <item>
            <title>[Clinical features and prognosis of primary biliary cirrhosis in Korea]</title>
            <link>http://www.medworm.com/index.php?rid=3867210&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606498%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Most patients diagnosed as PBC were asymptomatic, and these patients had a favorable short-term prognosis. The prognosis of PBC was dependent on the initial severity of liver disease.
    PMID: 20606498 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867210</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867210</guid>        </item>
        <item>
            <title>[Genotypic resistance to entecavir in chronic hepatitis B patients]</title>
            <link>http://www.medworm.com/index.php?rid=3867209&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606499%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We suspect that VBT is mostly associated with genotypic resistance to ETV. However, nonresponse might be associated with the continuance or reselection of the YMDD mutant in LAM-experienced patients.
    PMID: 20606499 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867209</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867209</guid>        </item>
        <item>
            <title>[Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b]</title>
            <link>http://www.medworm.com/index.php?rid=3867208&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606500%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The frequency of ISDR mutations was low in our cohort of Korean patients infected with HCV-Ib. Therefore, ISDR mutations might not contribute to the response to treatment with peginterferon plus ribavirin.
    PMID: 20606500 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867208</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867208</guid>        </item>
        <item>
            <title>[Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]</title>
            <link>http://www.medworm.com/index.php?rid=3867207&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606502%26dopt%3DAbstract</link>
            <description>We report the case of a 19-year-old male diagnosed as IPH with PVT and combined deficiencies in proteins C and S.
    PMID: 20606502 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867207</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867207</guid>        </item>
        <item>
            <title>[Toxic hepatitis associated with Polygoni multiflori]</title>
            <link>http://www.medworm.com/index.php?rid=3867206&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606503%26dopt%3DAbstract</link>
            <description>Authors: Bae SH, Kim DH, Bae YS, Lee KJ, Kim DW, Yoon JB, Hong JH, Kim SH
    Toxic hepatitis has been reported as a major cause of acute hepatitis, but its potential induction by herbal remedies and/or health foods is usually neglected. We experienced a case of toxic hepatitis associated with Polygoni multiflori, a Chinese herb commonly known as Ho-Shou-Wu. A 54-year-old woman consumed Ho-Shou-Wu for 1 month, after which she experienced fatigue and overall weakness. A diagnosis of toxic hepatitis was made based on her clinical history, the findings for viral markers and other laboratory data, and ultrasonography. Her condition improved considerably after she stopped taking Ho-Shou-Wu. However, she resumed taking Ho-Shou-Wu immediately after discharge from hospital, which aggravated her sy...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867206</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867206</guid>        </item>
        <item>
            <title>[Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C]</title>
            <link>http://www.medworm.com/index.php?rid=3867205&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606504%26dopt%3DAbstract</link>
            <description>We report a case of a 33-year-old female patient with chronic hepatitis C who simultaneously developed diabetic ketoacidosis and autoimmune thyroiditis after treatment with pegylated interferon-alpha 2b and ribavirin.
    PMID: 20606504 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867205</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867205</guid>        </item>
        <item>
            <title>[Infantile hemangioendothelioma with increased serum alpha-fetoprotein]</title>
            <link>http://www.medworm.com/index.php?rid=3867204&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606505%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 20606505 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867204</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867204</guid>        </item>
        <item>
            <title>[Hepatic tuberculosis presenting as a large liver mass]</title>
            <link>http://www.medworm.com/index.php?rid=3867203&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606506%26dopt%3DAbstract</link>
            <description>Authors: Shin YM
    
    PMID: 20606506 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3867203</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3867203</guid>        </item>
        <item>
            <title>[Prognosis of Korean patients with primary biliary cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=3737875&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606494%26dopt%3DAbstract</link>
            <description>Authors: Song BC
    
    PMID: 20606494 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737875</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737875</guid>        </item>
        <item>
            <title>[Pro-apoptotic function of hepatitis B virus X protein.]</title>
            <link>http://www.medworm.com/index.php?rid=3737874&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606495%26dopt%3DAbstract</link>
            <description>Authors: Kim KH
    Infection of hepatitis B virus (HBV) is a main cause of liver diseases including hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Among the HBV-encoded proteins, the HBV X protein (HBx) has been suspected to be strongly involved in HBV-associated liver pathogenesis. HBx, a virally encoded multifunctional regulator, has been shown to induce apoptosis, anti-apoptosis, proliferation, and transformation of cells depending on the cell lines, model systems used, assay protocols, and research groups. Among the several activities of HBx, the pro-apoptotic function of HBx will be discussed in this review. Given that the disruption of apoptosis pathway by HBx contributes to the liver pathogenesis, a better understanding of the molecular interference in the cellular pro-ap...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737874</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737874</guid>        </item>
        <item>
            <title>[Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan(R)) in patients with chronic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=3737873&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606496%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This study reveals that age, GGT, and albumin are clinical factors influencing LSM values. This reinforces the need to interpret LSM values in the context of a defined diagnosis, biochemical data, radiologic examination, and other clinical findings.
    PMID: 20606496 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737873</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737873</guid>        </item>
        <item>
            <title>[Clinical features of gas-forming liver abscesses: comparison between diabetic and nondiabetic patients.]</title>
            <link>http://www.medworm.com/index.php?rid=3737872&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606497%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Gas-forming liver abscesses are not uncommon in cases of pyogenic liver abscesses and are associated with high morbidity and mortality rates. The clinical manifestations and complications do not differ significantly between DM and non-DM patients.
    PMID: 20606497 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737872</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737872</guid>        </item>
        <item>
            <title>[Clinical features and prognosis of primary biliary cirrhosis in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=3737871&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606498%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Most patients diagnosed as PBC were asymptomatic, and these patients had a favorable short-term prognosis. The prognosis of PBC was dependent on the initial severity of liver disease.
    PMID: 20606498 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737871</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737871</guid>        </item>
        <item>
            <title>[Genotypic resistance to entecavir in chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=3737870&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606499%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We suspect that VBT is mostly associated with genotypic resistance to ETV. However, nonresponse might be associated with the continuance or reselection of the YMDD mutant in LAM-experienced patients.
    PMID: 20606499 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737870</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737870</guid>        </item>
        <item>
            <title>[Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b.]</title>
            <link>http://www.medworm.com/index.php?rid=3737869&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606500%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The frequency of ISDR mutations was low in our cohort of Korean patients infected with HCV-Ib. Therefore, ISDR mutations might not contribute to the response to treatment with peginterferon plus ribavirin.
    PMID: 20606500 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737869</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737869</guid>        </item>
        <item>
            <title>[Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?]</title>
            <link>http://www.medworm.com/index.php?rid=3737868&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606501%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In patients with preoperative AFP level &amp;gt;400 ng/ml, the AFP level tended to increase above 20 ng/ml at recurrence mostly within 1 year. Hence, we proposed that these patients could be monitored by only AFP until 1 year after surgery.
    PMID: 20606501 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737868</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737868</guid>        </item>
        <item>
            <title>[Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis.]</title>
            <link>http://www.medworm.com/index.php?rid=3737867&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606502%26dopt%3DAbstract</link>
            <description>We report the case of a 19-year-old male diagnosed as IPH with PVT and combined deficiencies in proteins C and S.
    PMID: 20606502 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737867</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737867</guid>        </item>
        <item>
            <title>[Toxic hepatitis associated with Polygoni multiflori.]</title>
            <link>http://www.medworm.com/index.php?rid=3737866&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606503%26dopt%3DAbstract</link>
            <description>Authors: Bae SH, Kim DH, Bae YS, Lee KJ, Kim DW, Yoon JB, Hong JH, Kim SH
    Toxic hepatitis has been reported as a major cause of acute hepatitis, but its potential induction by herbal remedies and/or health foods is usually neglected. We experienced a case of toxic hepatitis associated with Polygoni multiflori, a Chinese herb commonly known as Ho-Shou-Wu. A 54-year-old woman consumed Ho-Shou-Wu for 1 month, after which she experienced fatigue and overall weakness. A diagnosis of toxic hepatitis was made based on her clinical history, the findings for viral markers and other laboratory data, and ultrasonography. Her condition improved considerably after she stopped taking Ho-Shou-Wu. However, she resumed taking Ho-Shou-Wu immediately after discharge from hospital, which aggravated her sy...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737866</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737866</guid>        </item>
        <item>
            <title>[Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=3737865&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606504%26dopt%3DAbstract</link>
            <description>We report a case of a 33-year-old female patient with chronic hepatitis C who simultaneously developed diabetic ketoacidosis and autoimmune thyroiditis after treatment with pegylated interferon-alpha 2b and ribavirin.
    PMID: 20606504 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737865</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737865</guid>        </item>
        <item>
            <title>[Infantile hemangioendothelioma with increased serum alpha-fetoprotein.]</title>
            <link>http://www.medworm.com/index.php?rid=3737864&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606505%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 20606505 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737864</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737864</guid>        </item>
        <item>
            <title>[Hepatic tuberculosis presenting as a large liver mass.]</title>
            <link>http://www.medworm.com/index.php?rid=3737863&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606506%26dopt%3DAbstract</link>
            <description>Authors: Shin YM
    
    PMID: 20606506 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737863</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737863</guid>        </item>
        <item>
            <title>[Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotype 1 and 4 patients with slow virologic response.]</title>
            <link>http://www.medworm.com/index.php?rid=3737862&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20606507%26dopt%3DAbstract</link>
            <description>Authors: Kim IH
    
    PMID: 20606507 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3737862</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3737862</guid>        </item>
        <item>
            <title>[Predictors for virologic response in management of chronic hepatitis B]</title>
            <link>http://www.medworm.com/index.php?rid=3586574&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375637%26dopt%3DAbstract</link>
            <description>Authors: Lee JM, Ahn SH
    
    PMID: 20375637 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586574</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586574</guid>        </item>
        <item>
            <title>[Acute liver failure in Korea: etiology, prognosis and treatment]</title>
            <link>http://www.medworm.com/index.php?rid=3586573&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375638%26dopt%3DAbstract</link>
            <description>Authors: Lim YS
    Acute liver failure (ALF) is a rare condition in which rapid deterioration of liver function results in altered mentation and coagulopathy in individuals without previously recognized liver disease. The outcomes of patients with ALF vary greatly according to etiology, and the etiology of ALF varies markedly by geographical region. In Korea, about 90% of ALF are associated with etiologies that usually result in poor outcomes, including hepatitis B virus (HBV) infection and herbal remedies. The main causes of death in patients with ALF are increased intracranial pressure, systemic infection, and multi-organ failure. Recent advances in the intensive care of patients with ALF have contributed to a marked improvement in their overall survival. Emergency adult to adult living...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586573</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586573</guid>        </item>
        <item>
            <title>[Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes]</title>
            <link>http://www.medworm.com/index.php?rid=3586572&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375639%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results of this study indicate that the clinical condition of patients with HAV-related ALF requiring emergency LT aggravates rapidly. Prognostic parameters are not sufficient for discriminating transplant candidates in patients with fulminant hepatitis A.
    PMID: 20375639 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586572</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586572</guid>        </item>
        <item>
            <title>[Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]</title>
            <link>http://www.medworm.com/index.php?rid=3586571&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375640%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The simple and reproducible NAS was found to be a useful pathologic grading system in Korean NAFLD patients. However, the proportion of borderline cases based on the NAS was high. The &quot;wait and see&quot; strategy is necessary for evaluating the long-term prognosis.
    PMID: 20375640 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586571</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586571</guid>        </item>
        <item>
            <title>[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection]</title>
            <link>http://www.medworm.com/index.php?rid=3586570&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375641%26dopt%3DAbstract</link>
            <description>CONCLUSION: The combination therapy of PEG-IFN and ribavirin exhibited a low efficacy in cirrhotic patients with HCV infection and was associated with frequent serious complications. However, with careful management of complications, the therapy may have a considerable efficacy in some patients with cirrhosis and HCV infection.
    PMID: 20375641 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586570</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586570</guid>        </item>
        <item>
            <title>[The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study]</title>
            <link>http://www.medworm.com/index.php?rid=3586569&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375642%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: There was no significant association between seropositivity for HBsAg or anti-HCV and PC. Further studies are warranted to clarify the association between HBV infection and PC in regions where HBV is endemic.
    PMID: 20375642 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586569</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586569</guid>        </item>
        <item>
            <title>[Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B]</title>
            <link>http://www.medworm.com/index.php?rid=3586568&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375643%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Entecavir therapy showed excellent efficacy in nucleoside-naive chronic hepatitis B patients. The predictors of a virologic response were an absence of HBeAg and a low baseline HBV DNA level.
    PMID: 20375643 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586568</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586568</guid>        </item>
        <item>
            <title>[Diagnostic usefulness of the random urine Na/K ratio in cirrhotic patients with ascites: a pilot study]</title>
            <link>http://www.medworm.com/index.php?rid=3586567&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375644%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results suggest that anytime random UNa/K greater than 1.25 is an accurate, cost-effective, and convenient method for replacing 24-h UNa. Large multicentered cohort studies are needed to confirm our results.
    PMID: 20375644 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586567</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586567</guid>        </item>
        <item>
            <title>[A case report of alverine-citrate-induced acute hepatitis]</title>
            <link>http://www.medworm.com/index.php?rid=3586566&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375645%26dopt%3DAbstract</link>
            <description>We present a case of a 75-year-old female patient who experienced complicated jaundice and abdominal discomfort after taking alverine citrate. Other causes of hepatitis were ruled out and the results of the liver function test returned to normal after ceasing the drug. This is the first case report in Korea of alverine-citrate-induced hepatotoxicity.
    PMID: 20375645 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586566</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586566</guid>        </item>
        <item>
            <title>[A case of hemophagocytic syndrome complicated by acute viral hepatitis A infection]</title>
            <link>http://www.medworm.com/index.php?rid=3586565&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375646%26dopt%3DAbstract</link>
            <description>We report a case of a 22-year-old woman infected by hepatitis A virus who was consequently complicated with HPS. She presented typical clinical features of acute hepatitis A, and showed clinical and biochemical improvements. However, HPS developed as a complication of acute hepatitis A and the patient died of intraperitoneal bleeding caused by hepatic decompensation and disseminated intravascular coagulation.
    PMID: 20375646 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586565</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586565</guid>        </item>
        <item>
            <title>[Sarcomatoid hepatocellular carcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=3586564&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375648%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 20375648 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586564</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586564</guid>        </item>
        <item>
            <title>[Hepatic eosinophilic abscess presenting as a single nodular mass]</title>
            <link>http://www.medworm.com/index.php?rid=3586563&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375649%26dopt%3DAbstract</link>
            <description>Authors: Shin YM
    
    PMID: 20375649 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586563</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586563</guid>        </item>
        <item>
            <title>[Predictors for virologic response in management of chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=3454373&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375637%26dopt%3DAbstract</link>
            <description>Authors: Lee JM, Ahn SH
    
    PMID: 20375637 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454373</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454373</guid>        </item>
        <item>
            <title>[Acute liver failure in Korea: etiology, prognosis and treatment.]</title>
            <link>http://www.medworm.com/index.php?rid=3454372&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375638%26dopt%3DAbstract</link>
            <description>Authors: Lim YS
    Acute liver failure (ALF) is a rare condition in which rapid deterioration of liver function results in altered mentation and coagulopathy in individuals without previously recognized liver disease. The outcomes of patients with ALF vary greatly according to etiology, and the etiology of ALF varies markedly by geographical region. In Korea, about 90% of ALF are associated with etiologies that usually result in poor outcomes, including hepatitis B virus (HBV) infection and herbal remedies. The main causes of death in patients with ALF are increased intracranial pressure, systemic infection, and multi-organ failure. Recent advances in the intensive care of patients with ALF have contributed to a marked improvement in their overall survival. Emergency adult to adult living...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454372</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454372</guid>        </item>
        <item>
            <title>[Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes.]</title>
            <link>http://www.medworm.com/index.php?rid=3454371&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375639%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results of this study indicate that the clinical condition of patients with HAV-related ALF requiring emergency LT aggravates rapidly. Prognostic parameters are not sufficient for discriminating transplant candidates in patients with fulminant hepatitis A.
    PMID: 20375639 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454371</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454371</guid>        </item>
        <item>
            <title>[Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors.]</title>
            <link>http://www.medworm.com/index.php?rid=3454370&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375640%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The simple and reproducible NAS was found to be a useful pathologic grading system in Korean NAFLD patients. However, the proportion of borderline cases based on the NAS was high. The &quot;wait and see&quot; strategy is necessary for evaluating the long-term prognosis.
    PMID: 20375640 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454370</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454370</guid>        </item>
        <item>
            <title>[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection.]</title>
            <link>http://www.medworm.com/index.php?rid=3454369&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375641%26dopt%3DAbstract</link>
            <description>CONCLUSION: The combination therapy of PEG-IFN and ribavirin exhibited a low efficacy in cirrhotic patients with HCV infection and was associated with frequent serious complications. However, with careful management of complications, the therapy may have a considerable efficacy in some patients with cirrhosis and HCV infection.
    PMID: 20375641 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454369</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454369</guid>        </item>
        <item>
            <title>[The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study.]</title>
            <link>http://www.medworm.com/index.php?rid=3454368&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375642%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: There was no significant association between seropositivity for HBsAg or anti-HCV and PC. Further studies are warranted to clarify the association between HBV infection and PC in regions where HBV is endemic.
    PMID: 20375642 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454368</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454368</guid>        </item>
        <item>
            <title>[Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=3454367&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375643%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Entecavir therapy showed excellent efficacy in nucleoside-naive chronic hepatitis B patients. The predictors of a virologic response were an absence of HBeAg and a low baseline HBV DNA level.
    PMID: 20375643 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454367</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454367</guid>        </item>
        <item>
            <title>[Diagnostic usefulness of the random urine Na/K ratio in cirrhotic patients with ascites: a pilot study.]</title>
            <link>http://www.medworm.com/index.php?rid=3454366&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375644%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results suggest that anytime random UNa/K greater than 1.25 is an accurate, cost-effective, and convenient method for replacing 24-h UNa. Large multicentered cohort studies are needed to confirm our results.
    PMID: 20375644 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454366</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454366</guid>        </item>
        <item>
            <title>[A case report of alverine-citrate-induced acute hepatitis.]</title>
            <link>http://www.medworm.com/index.php?rid=3454365&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375645%26dopt%3DAbstract</link>
            <description>We present a case of a 75-year-old female patient who experienced complicated jaundice and abdominal discomfort after taking alverine citrate. Other causes of hepatitis were ruled out and the results of the liver function test returned to normal after ceasing the drug. This is the first case report in Korea of alverine-citrate-induced hepatotoxicity.
    PMID: 20375645 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454365</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454365</guid>        </item>
        <item>
            <title>[A case of hemophagocytic syndrome complicated by acute viral hepatitis A infection.]</title>
            <link>http://www.medworm.com/index.php?rid=3454364&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375646%26dopt%3DAbstract</link>
            <description>We report a case of a 22-year-old woman infected by hepatitis A virus who was consequently complicated with HPS. She presented typical clinical features of acute hepatitis A, and showed clinical and biochemical improvements. However, HPS developed as a complication of acute hepatitis A and the patient died of intraperitoneal bleeding caused by hepatic decompensation and disseminated intravascular coagulation.
    PMID: 20375646 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454364</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454364</guid>        </item>
        <item>
            <title>Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.</title>
            <link>http://www.medworm.com/index.php?rid=3454363&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375647%26dopt%3DAbstract</link>
            <description>We described a 20-year-old male with severe liver disease who was diagnosed with EPP based on clinical and laboratory findings. He was treated with cholestyramine resin. Six months after the treatment, he was doing well without any abdominal pain or photosensitivity.
    PMID: 20375647 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454363</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454363</guid>        </item>
        <item>
            <title>[Sarcomatoid hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=3454362&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375648%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 20375648 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454362</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454362</guid>        </item>
        <item>
            <title>[Hepatic eosinophilic abscess presenting as a single nodular mass.]</title>
            <link>http://www.medworm.com/index.php?rid=3454361&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375649%26dopt%3DAbstract</link>
            <description>Authors: Shin YM
    
    PMID: 20375649 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454361</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454361</guid>        </item>
        <item>
            <title>Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=3454360&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20375650%26dopt%3DAbstract</link>
            <description>Authors: Kwon OS
    
    PMID: 20375650 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3454360</comments>
            <pubDate>Mon, 01 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3454360</guid>        </item>
        <item>
            <title>Current status of liver diseases in Korea: hepatitis B.</title>
            <link>http://www.medworm.com/index.php?rid=3444231&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037275%26dopt%3DAbstract</link>
            <description>Authors: Chae HB, Kim JH, Kim JK, Yim HJ
    Hepatitis B virus (HBV) infection is the one of the most common causes of the liver diseases in Korea. Since the discovery of Australia antigen (hepatitis associated antigen, or HBsAg later), hepatitis associated antigen was tested widely. HBsAg was detected in 6.6-8.6% in 1980's. Later, it decreased to 5.7% in 1990's. Remarkably, seropositivity of the children deceased to 0.2% after the nationwide vaccination program. Although hepatitis B vaccines are highly effective, the failure rate of perinatal prophylaxis in babies born to HBsAg positive mother was reported to be 4.25%. Treatment of chronic hepatitis B was initiated after the introduction of interferon alpha. Lamivudine opened a new era of oral antiviral agent, and it has been widely used ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444231</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444231</guid>        </item>
        <item>
            <title>Current status of liver disease in Korea: hepatitis C.</title>
            <link>http://www.medworm.com/index.php?rid=3444230&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037276%26dopt%3DAbstract</link>
            <description>Authors: Lim YS
    Chronic hepatitis C (CHC) is the third most common cause of chronic liver disease and hepatocellular carcinoma (HCC) in Korea, following hepatitis B virus (HBV) infection and alcohol. HCV prevalence among Koreans older than 40 years of age has been estimated to be 1.29%. The prevalence of CHC increases with age, with the peak prevalence at the age of 60 or older. Blood transfusions have generated no risk of HCV infection since April 1991, when routine screening for anti-HCV in blood donors was adopted in Korea. Although injection drug use seems to be one of the most important risk factors of HCV infection among young adults in urban areas, the majority of CHC patients are not associated with injection drug use. Exposure to acupuncture was identified as a significant ris...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444230</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444230</guid>        </item>
        <item>
            <title>Current status of liver diseases in Korea: toxic and alcoholic liver diseases.</title>
            <link>http://www.medworm.com/index.php?rid=3444229&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037277%26dopt%3DAbstract</link>
            <description>Authors: Kim KA
    The study of the epidemiology of toxic liver injury has been limited in Korea. The number of hospitalizations for toxic liver injury has been estimated to be 2,400 persons per year. About 30~40% of fulminant hepatitis was attributed to toxic hepatitis. The frequent causative agents of toxic hepatitis in Korea are herbal medicines (34-40%), folk remedies (23-34%), and prescribed medicines (24-55%). However, the most common agents causing severe liver injury including fulminant hepatitis are herbal medicine and folk remedies. Antituberculosis drugs and acetaminophen are two common causes of fulminant hepatitis among prescribed drugs. Alcohol is one of the leading causes of chronic liver disease in Korea. No nationwide study on the epidemiology of alcoholic liver disease (...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444229</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444229</guid>        </item>
        <item>
            <title>Current status of liver disease in Korea: nonalcoholic fatty liver disease.</title>
            <link>http://www.medworm.com/index.php?rid=3444228&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037278%26dopt%3DAbstract</link>
            <description>Authors: Park SH
    Recently, obesity (BMI&amp;gt;or=25 kg/m2) and type II diabetes mellitus have reached epidemic proportions in Korea, and rates of nonalcoholic fatty liver disease (NAFLD) are between 10% and 25% of the general population. NAFLD in Korea is as closely associated with several components of metabolic syndrome including, obesity, hypertension, diabetes and dyslipidemia as it is in Western countries. Insulin resistance and hyperinsulinemia may play a role in the pathogenesis of fatty liver in patients with normal body weight as well as in patients with obesity. And, obesity induced accumulation of fat in the adipose tissue leads to an imbalance in the regulation of adipokines, such as downregulation of adiponectin and upregulation of retinol-binding protein 4 (RBP4) and ghrelin...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444228</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444228</guid>        </item>
        <item>
            <title>Current status of liver diseases in Korea: liver cirrhosis.</title>
            <link>http://www.medworm.com/index.php?rid=3444227&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037279%26dopt%3DAbstract</link>
            <description>Authors: Jang JW
    Liver cirrhosis represents the final common pathway of virtually all chronic liver diseases, and is characterized by an accumulation of extracellular matrix rich in fibrillar collagens. Patients with cirrhosis are at risk of developing many potential complications. The most common complication seen in patients with liver cirrhosis is ascites, and the most lethal one is bleeding varices. Other intermediate and late stage complications include spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome. The mortality and morbidity attributable to liver disease in Korea have decreased continuously over the past decades, probably due to the implementation of universal vaccination and potent antiviral therapies. In addition, recent advances in the un...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444227</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444227</guid>        </item>
        <item>
            <title>Current status of liver diseases in Korea: hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=3444226&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037280%26dopt%3DAbstract</link>
            <description>Authors: Song IH, Kim KS
    Primary liver cancer, most of which is hepatocellular carcinoma (HCC), is the third common leading cancer in Korea. During the last two decades, the incidence rate of primary liver cancer has shown a modest decrease, but its mortality rate has slightly increased. The incidence of HCC, according to age, peaks in the late sixth decade in men and in the early seventh decade in women. Hepatitis B virus (HBV) is the most important risk factor, which represents approximately 70% of all HCC, and hepatitis C virus (HCV) and alcohol are the next in order of major risk factors for the development of HCC in Korea. HBV-associated HCC occurs 10 years earlier than HCV-associated HCC due to a more prolonged exposure to HBV, which is vertically transmitted almost from HBsAg-po...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444226</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444226</guid>        </item>
        <item>
            <title>Current status of hepatic surgery in Korea.</title>
            <link>http://www.medworm.com/index.php?rid=3444225&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037281%26dopt%3DAbstract</link>
            <description>Authors: Kim KS
    Since the first liver resection was carried out in Korea in 1959, there have been remarkable changes in the field of surgery. With technical advancement and the improvement of perioperative care, liver resections are widely performed and surgical mortality is approaching zero. In the early 1990s, liver transplantation evolved as a feasible option in the treatment of end-stage liver disease in Korea, with successful adult living-donor liver transplantation (LDLT) as one of the greatest achievements. Various innovations in surgical approaches have been introduced. We review the current status of hepatic surgery in liver disease in Korea.
    PMID: 20037281 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444225</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444225</guid>        </item>
        <item>
            <title>Current status of liver diseases in Korea: hepatitis A.</title>
            <link>http://www.medworm.com/index.php?rid=3444224&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037282%26dopt%3DAbstract</link>
            <description>Authors: Kwon SY
    The seroprevalence of anti-HAV (hepatitis A virus) has been decreasing in Korea. The decrease in HAV infection in young adults has resulted in the reduction of individuals with protective antibody and an increase in hepatitis A in the adult population. The increase in HAV infection in adults will have an impact on the magnitude and severity of the disease. In Korea, symptomatic hepatitis A has been gradually increasing since the mid-1990s, with a tendency toward an increase in mean age and disease severity. The endemic genotype of HAV in Korea has been changing from genotype IA alone to a mixture of genotype IA and IIIA. Therefore, preventive measures including universal vaccination in infants and active immunization of the adult population should be considered.
    PM...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444224</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444224</guid>        </item>
        <item>
            <title>[Transient elastography, true or false?]</title>
            <link>http://www.medworm.com/index.php?rid=3127041&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037261%26dopt%3DAbstract</link>
            <description>Authors: Seo YS
    
    PMID: 20037261 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127041</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127041</guid>        </item>
        <item>
            <title>[Epidemiology and clinical features of acute hepatitis A: from the domestic perspective.]</title>
            <link>http://www.medworm.com/index.php?rid=3127040&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037262%26dopt%3DAbstract</link>
            <description>Authors: Jung YK, Kim JH
    Acute viral hepatitis A has recently become a major public health problem in Korea, and the incidence of symptomatic hepatitis A is growing rapidly. With improvements in socioeconomic conditions and environmental hygiene, the chances of exposure to hepatitis A virus (HAV) during childhood have decreased and, in turn, the proportion of young adults with positive anti-HAV has significantly decreased. This has led to the incidence of symptomatic acute hepatitis A increasing since the late 1990s. The incidence of serious complications including fulminant hepatic failure and acute kidney injury has also showed an increasing trend. Variation of the genotype of virus isolated from recent hepatitis A patients suggests an inflow of the hepatitis virus from other countri...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127040</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127040</guid>        </item>
        <item>
            <title>[Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=3127039&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037263%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Entecavir induced excellent biochemical and virologic responses in naive CHB patients. EVR was an independent factor for predicting HBV PCR negativity and HBeAg loss.
    PMID: 20037263 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127039</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127039</guid>        </item>
        <item>
            <title>[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=3127038&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037264%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: All noninvasive serum markers evaluated in this study were useful for predicting significant or extensive liver fibrosis in chronic viral liver diseases. In particular, APRI was most useful for the prediction of significant fibrosis, and CDS was most useful for the prediction of extensive fibrosis.
    PMID: 20037264 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127038</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127038</guid>        </item>
        <item>
            <title>[Factors associated with liver stiffness in chronic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=3127037&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037265%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Liver stiffness as measured by transient elastography is associated with the grade of necroinflammatory activity and the stage of fibrosis, irrespective of serum ALT levels.
    PMID: 20037265 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127037</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127037</guid>        </item>
        <item>
            <title>[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm.]</title>
            <link>http://www.medworm.com/index.php?rid=3127036&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037266%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: TACE and RFA exhibited similar therapeutic effects in terms of recurrence and survival for patients with a single HCC smaller than 4 cm, if they could exhibited complete responses.
    PMID: 20037266 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127036</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127036</guid>        </item>
        <item>
            <title>Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB.</title>
            <link>http://www.medworm.com/index.php?rid=3127035&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037267%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The up-regulated expression of FZD10 and CAMK2A suggests that the Wnt/Ca(2+) signaling pathway is active in hTERT HSCs and may participate in HSC activation and proliferation.
    PMID: 20037267 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127035</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127035</guid>        </item>
        <item>
            <title>[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=3127034&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037268%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The 24-week plus additional split 24-week therapy following failure is a useful treatment strategy for patients with genotype 1 CHC.
    PMID: 20037268 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127034</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127034</guid>        </item>
        <item>
            <title>[Two cases of toxic hepatitis caused by arrowroot juice.]</title>
            <link>http://www.medworm.com/index.php?rid=3127033&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037269%26dopt%3DAbstract</link>
            <description>We describe two cases of symptomatic toxic hepatitis that developed in middle-aged women after ingesting arrowroot juice. The clinical manifestations were nausea, vomiting, and jaundice. The diagnosis of toxic hepatitis was made using the Roussel Uclaf Causality Assessment Method score on the basis of the patient's history and laboratory data. After supportive care, the patients showed rapid improvements of clinical symptoms, laboratory findings, and liver stiffness. Clinicians should be aware that the consumption of arrowroot juice can cause toxic hepatitis.
    PMID: 20037269 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127033</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127033</guid>        </item>
        <item>
            <title>[A case of primary hepatic epithelioid hemangioendothelioma with spontaneous rupture.]</title>
            <link>http://www.medworm.com/index.php?rid=3127032&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037270%26dopt%3DAbstract</link>
            <description>We present a case of primary hepatic epithelioid hemangioendothelioma in a 65-year-old male patient with alcoholic liver cirrhosis. He was hospitalized due to epigastric pain and multiple liver masses on abdominal ultrasound. Dynamic liver CT imaging revealed multiple peripheral nodular enhanced mass lesions with delayed centripetal enhancement, and the adjacent collection of high-attenuation fluid along the liver capsule. Abdominal tapping revealed blood in the peritoneal cavity. Primary hepatic epithelioid hemangioendothelioma with spontaneous rupture was finally diagnosed based on a histopathologic examination revealing positive immunohistochemical staining for CD34.
    PMID: 20037270 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127032</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127032</guid>        </item>
        <item>
            <title>[A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.]</title>
            <link>http://www.medworm.com/index.php?rid=3127031&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037271%26dopt%3DAbstract</link>
            <description>We report herein a case of hepatotoxicity induced by Corydalis speciosa Max. A 37-year-old male complained of jaundice and mild abdominal discomfort. A thorough history was taken, and laboratory investigation, diagnostic imaging studies, and percutaneous liver biopsy sampling were conducted to determine the cause of liver injury. An accurate cause was not revealed. We administered supportive management for acute cholestatic hepatitis of unknown origin, after which his symptoms disappeared and serum aminotransferase levels decreased gradually to near normal levels. However, at 2 months after discharge, the symptoms and the elevation of aminotransferase levels recurred. At that time he told us that he had repeatedly but unintentionally eaten a herb called &quot;Hwang-geun cho&quot;(Corydalis speciosa ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127031</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127031</guid>        </item>
        <item>
            <title>[Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection.]</title>
            <link>http://www.medworm.com/index.php?rid=3127030&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037272%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    
    PMID: 20037272 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127030</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127030</guid>        </item>
        <item>
            <title>[Neuroendocrine tumors of the liver.]</title>
            <link>http://www.medworm.com/index.php?rid=3127029&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037273%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 20037273 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127029</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127029</guid>        </item>
        <item>
            <title>[Role of cadherin-17 in hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=3127028&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037274%26dopt%3DAbstract</link>
            <description>Authors: Hahn T
    
    PMID: 20037274 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127028</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127028</guid>        </item>
        <item>
            <title>[Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2843181&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783878%26dopt%3DAbstract</link>
            <description>Authors: Jin HS, Oh B
    
    PMID: 19783878 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843181</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843181</guid>        </item>
        <item>
            <title>Molecular targeting for treatment of advanced hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=2843180&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783879%26dopt%3DAbstract</link>
            <description>Authors: Song IH
    Hepatocellular carcinoma (HCC) is a major global health problem, which has a grave morbidity and mortality. Over the past few decades, no effective systemic therapeutic modalities have been established for patients with the unresectable HCC in advanced stage. Sorafenib is a small molecule that blocks cancer cell proliferation by targeting the intracellular signaling pathway at the level of Raf-1 and B-Raf serine-threonine kinases, and exerts an anti-angiogenic effect by targeting the vascular endothelial growth factor receptor-1, 2 and 3, and platelet-derived growth factor receptor-beta tyrosine kinases. Recently, two clinical successful applications, SHARP and Asia-Pacific trial, of multikinase inhibitor sorafenib represent a significant advance in the treatment of ad...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843180</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843180</guid>        </item>
        <item>
            <title>[Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2843179&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783880%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The arche haplotype of the ATP7B gene in Korean patients with WD may be 5-R778L-4 (D13S315.mutation.D13S316), and it might illustrate a founder effect.
    PMID: 19783880 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843179</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843179</guid>        </item>
        <item>
            <title>Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.</title>
            <link>http://www.medworm.com/index.php?rid=2843178&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783881%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Serum OPN levels were significantly higher in patients with advanced HCC. In addition, HCC patients with low pretreatment serum OPN levels and those for whom serum OPN declined following TACE exhibited better tumor responses and survived for longer.
    PMID: 19783881 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843178</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843178</guid>        </item>
        <item>
            <title>[Efficacy of 48-week clevudine therapy for chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2843177&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783882%26dopt%3DAbstract</link>
            <description>CONCLUSION: A 48-week course of clevudine therapy was highly effective in patients with CHB. The risk of development of resistance to clevudine was increased in patients with previous exposure to lamivudine and cirrhosis.
    PMID: 19783882 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843177</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843177</guid>        </item>
        <item>
            <title>Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.</title>
            <link>http://www.medworm.com/index.php?rid=2843176&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783883%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Adherence to therapy is a key factor in achieving an SVR. Supportive strategies to improve adherence will increase overall SVR rates.
    PMID: 19783883 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843176</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843176</guid>        </item>
        <item>
            <title>[Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843175&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783884%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Both MELD and HVPG are independent prognostic factors of death within 3 and 12 months in patients with decompensated liver cirrhosis, and their accuracies are similar. However, HVPG has a limited role in the prediction of death in decompensated cirrhosis due to its invasiveness and limited use.
    PMID: 19783884 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843175</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843175</guid>        </item>
        <item>
            <title>[A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization.]</title>
            <link>http://www.medworm.com/index.php?rid=2843174&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783885%26dopt%3DAbstract</link>
            <description>We report a rare case of rib metastasis from HCC treated by transcatheter arterial chemoembolization (TACE). A 55-year-old man with liver cirrhosis presented with right lower chest pain. The diagnosis was an HCC with a bone metastasis in the right eighth rib. Intra-arterial injections of doxorubicin mixed with Lipiodol and Gelfoam particles were instituted through the right eighth intercostal artery. Computed tomography and a Tc(99)-labeled scan performed 2 months after the third TACE revealed no viable HCC in the right eighth rib.
    PMID: 19783885 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843174</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843174</guid>        </item>
        <item>
            <title>[Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation.]</title>
            <link>http://www.medworm.com/index.php?rid=2843173&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783886%26dopt%3DAbstract</link>
            <description>We report four cases of hepatitis A in which patients presented with fulminant hepatitis and acute renal failure and underwent liver transplantation. The following common features were observed in our cases: (1) occurrence in relatively old age (&amp;gt;/=39 years old), (2) association with acute renal failure, (3) presence of hepatomegaly, and (4) microscopic features of submassive hepatic necrosis.
    PMID: 19783886 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843173</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843173</guid>        </item>
        <item>
            <title>[A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=2843172&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783887%26dopt%3DAbstract</link>
            <description>We report a 60-year-old male patient who developed sudden-onset hearing loss during combination therapy with pegylated interferon alpha and ribavirin for chronic hepatitis C. This patient had been diagnosed with chronic hepatitis C (genotype Ib) and early-stage liver cirrhosis 3 years previously, and had been treated with conventional interferon-alpha and ribavirin for 12 months. However, 6 months from the end of the treatment course the patient relapsed and received combination retreatment with pegylated interferon alpha-2b and ribavirin. He developed sudden-onset right-side hearing loss and tinnitus 42 weeks after the start of this retreatment. Pure-tone audiometry revealed a right-side hearing loss of 60~90dB. The patient consequently immediately discontinued the pegylated interferon th...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843172</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843172</guid>        </item>
        <item>
            <title>[Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843171&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783888%26dopt%3DAbstract</link>
            <description>Authors: Kim H, Park YN
    
    PMID: 19783888 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843171</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843171</guid>        </item>
        <item>
            <title>[Peliosis hepatis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843170&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783889%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19783889 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843170</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843170</guid>        </item>
        <item>
            <title>[Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2843169&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783890%26dopt%3DAbstract</link>
            <description>Authors: Kim JH
    
    PMID: 19783890 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843169</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843169</guid>        </item>
        <item>
            <title>[Practice guidelines for management of hepatocellular carcinoma 2009.]</title>
            <link>http://www.medworm.com/index.php?rid=2843168&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783891%26dopt%3DAbstract</link>
            <description>Authors:  
    Hepatocellular carcinoma (HCC) is a major cancer in Korea, typically has a poor prognosis, and constitutes the majority of primary hepatic malignancies. It is the number one cause of death among people in their 50s in Korea. The five-year survival rate of liver cancer is poor; at 18.9%. Efforts to increase the survival rate through early diagnosis of HCC and optimal treatments are keenly needed. Western guideline for the management of HCC were developed, but these guidelines are somewhat unsuitable for Korean patients. Thus, the Korean Liver Cancer Study Group (KLCSG) and the National Cancer Center (NCC), Korea jointly produced the Clinical Practice Guidelines for HCC for the first time in Korea in 2003. Owing to medical advances over the following six years, diagnosis and t...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843168</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843168</guid>        </item>
        <item>
            <title>[Corrections: Distribution of hepatitis B virus genotypes in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2843167&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783892%26dopt%3DAbstract</link>
            <description>Authors: Cho JH, Yoon KH, Lee KE, Park do S, Lee YJ, Moon HB, Lee KR, Choi CS, Cho EY, Kim HC
    
    PMID: 19783892 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843167</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843167</guid>        </item>
        <item>
            <title>[Clevudine therapy in patients with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2581438&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581763%26dopt%3DAbstract</link>
            <description>Authors: Lee KS
    
    PMID: 19581763 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581438</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581438</guid>        </item>
        <item>
            <title>[Pathology of nonalcoholic steatohepatitis.]</title>
            <link>http://www.medworm.com/index.php?rid=2581437&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581764%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    Nonalcoholic steatohepatitis (NASH), one of the NAFLDs (nonalcoholic fatty liver diseases), is regarded as a hepatic manifestation of metabolic syndrome. NASH can progress to cirrhosis, and possibly to hepatic malignancy. Currently, liver biopsy is the only reliable method of assessing the presence or absence of NASH and the stage of fibrosis. The finding of steatosis with evidence of hepatocyte injury such as inflammation, ballooning, degeneration, and/or fibrosis, is generally essential for making a diagnosis of NASH. However, its diagnostic criteria have not yet been established. The pathologic findings of NASH and related diseases, and the grading system currently in use are reviewed herein.
    PMID: 19581764 [PubMed - in process] (Source: Korean J Hepatol...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581437</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581437</guid>        </item>
        <item>
            <title>[Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation.]</title>
            <link>http://www.medworm.com/index.php?rid=2581436&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581765%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Due to the adoptive immunity that was transferred from anti-HBs-positive donors, a seroconversion of HBsAg could occur in some HBsAg-positive recipients. HBsAg-positive donors had a lesser effect on the HBV serologic markers of recipients. However, a reactivation of HBV can occur following hematopoietic stem-cell transplantation in the cases of recipients or donors with a history of HBV, infection by an accompanying immune suppression. Therefore, prevention should be instigated.
    PMID: 19581765 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581436</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581436</guid>        </item>
        <item>
            <title>[Distribution of hepatitis B virus genotypes in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2581435&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581766%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The prevailing HBV genotype in Korea is C2; the other genotypes occur only rarely. Future studies should include confirmation of the detection of genotypes other than C.
    PMID: 19581766 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581435</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581435</guid>        </item>
        <item>
            <title>[Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581434&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581767%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The prognosis in patients with ruptured HCCs was poor with a 30-day mortality of 43.5%. The early deaths after the rupture of HCC were associated with elevated serum bilirubin levels, hepatic encephalopathy, and the massive or diffuse type of tumor morphology.
    PMID: 19581767 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581434</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581434</guid>        </item>
        <item>
            <title>[Clinical features of hepatic tuberculosis in biopsy-proven cases.]</title>
            <link>http://www.medworm.com/index.php?rid=2581433&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581768%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In patients with a protracted illness, hepatosplenomegaly and/or abnormal liver function tests, hepatic tuberculosis should be suspected, even in healthy young patients or patients with normal imaging findings. Patients with tuberculous abscess formation tend to respond poorly to antituberculosis therapy, and surgery could be considered in these patients.
    PMID: 19581768 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581433</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581433</guid>        </item>
        <item>
            <title>[Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2581432&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581769%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Younger children (age &amp;lt;7 years old) have a higher chance of HBsAg clearance than older children after the treatment of HBeAg-positive chronic hepatitis B with lamivudine.
    PMID: 19581769 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581432</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581432</guid>        </item>
        <item>
            <title>[Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases.]</title>
            <link>http://www.medworm.com/index.php?rid=2581431&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581770%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Clevudine is one of the recommended first-line medicines for the treatment of chronic hepatitis B, but it is not free from resistance, particularly in patients with a history of previous lamivudine treatment, but also in naive patients. Clevudine should be avoided in previously lamivudine-exposed patients. In addition, reelevation of serum AST and CPK levels is not a rare occurrence, and close observation and follow-up tests are essential.
    PMID: 19581770 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581431</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581431</guid>        </item>
        <item>
            <title>[A case of hypervascular hyperplastic nodules mimicking hepatocellular carcinoma in alcoholic liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2581430&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581771%26dopt%3DAbstract</link>
            <description>We report herein a case of benign HHN mimicking hepatocellular carcinoma in a 32-year-old male alcoholic liver cirrhosis patient without viral hepatitis infection.
    PMID: 19581771 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581430</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581430</guid>        </item>
        <item>
            <title>[A case of liver metastasis of gastric hepatoid adenocarcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581429&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581772%26dopt%3DAbstract</link>
            <description>We report herein a case of hepatoid adenocarcinoma of the stomach with liver metastasis. Gastric carcinoma generally presents as adenocarcinoma and rarely shows a hepatoid pattern, which can produce alpha-fetoprotein (AFP). The stomach is one of the common sites at which hepatoid adenocarcinoma has been detected. A 75-year-old female patient was admitted to the hospital with a symptom of epigastric discomfort. Gastrofibroscopy revealed a large tumor occupying the greater curvature of the stomach body. The level of serum AFP was markedly increased. Abdominal computed tomography revealed multiple liver masses. Biopsy samples of the gastric lesion and liver masses finally confirmed her case as hepatoid adenocarcinoma in the stomach with liver metastasis. The AFP-producing gastric carcinoma ne...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581429</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581429</guid>        </item>
        <item>
            <title>Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.</title>
            <link>http://www.medworm.com/index.php?rid=2581428&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581773%26dopt%3DAbstract</link>
            <description>Authors: Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH
    A 63-year-old male experienced sudden diplopia after 9 weeks of administration of pegylated interferon (IFN) alpha-2b and ribavirin for chronic hepatitis C (CHC). Ophthalmologic examinations showed ptosis on the right upper lid and restricted right eye movement without any other neurological signs. A brain imaging study and repetitive nerve stimulation test indicated no abnormality. The acetylcholine receptor antibody titer and response to acetylcholinesterase inhibitors were negative, and the results of thyroid function tests were normal. The patient's ophthalmological symptoms improved rapidly 3 weeks after discontinuation of pegylated IFN alpha-2b and ribavirin. The ocular myasthenia associated with combination therapy of pegylat...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581428</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581428</guid>        </item>
        <item>
            <title>[Primary angiosarcoma of the liver.]</title>
            <link>http://www.medworm.com/index.php?rid=2581427&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581774%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 19581774 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581427</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581427</guid>        </item>
        <item>
            <title>[Epithelioid hemangioendothelioma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581426&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581775%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19581775 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581426</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581426</guid>        </item>
        <item>
            <title>Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=2581425&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581776%26dopt%3DAbstract</link>
            <description>Authors: Heo J
    
    PMID: 19581776 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581425</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581425</guid>        </item>
        <item>
            <title>[Inhibition of hepatitis B virus replication by RNA interference.]</title>
            <link>http://www.medworm.com/index.php?rid=2309369&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346780%26dopt%3DAbstract</link>
            <description>Authors: Park YG
    
    PMID: 19346780 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309369</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309369</guid>        </item>
        <item>
            <title>[Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2309367&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346781%26dopt%3DAbstract</link>
            <description>Authors: Kim YJ, Lee HS
    Hepatocellular carcinoma (HCC) is associated with hepatitis B virus (HBV) as an etiologic agent in 80% of cases, and is the major cause of death among HBV carriers. Family history of HCC is a known risk factor for the development of HCC among chronically HBV infected patients; therefore, genetic factors are likely to modify the risk of HCC. However, the genetic factors that determine progression to HCC remain mostly to be recovered. It is estimated that there are millions of single nucleotide polymorphisms (SNPs) within human genome and they are likely to explain much of the genetic diversity of individuals. In this review, the natural history of HBV infection and host genetic factors related to HCC, study design and target gene selection for the detection of SN...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309367</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309367</guid>        </item>
        <item>
            <title>[Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx.]</title>
            <link>http://www.medworm.com/index.php?rid=2309365&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346782%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Lentivirus-mediated delivery of shRNA against HBx can effectively suppress the replication of HBV and reduce HBV cccDNA in cell culture systems.
    PMID: 19346782 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309365</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309365</guid>        </item>
        <item>
            <title>[Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2309363&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346783%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Antiviral treatment of CHB with LMV or ADV for up to 5 years using the alternative antiviral agent as rescue medication appears to be a cost-effective strategy for both HBeAg-positive and HBeAg-negative CHB patients in Korea. Economic evaluation of antiviral therapies should be studied further and updated, particularly for newer agents.
    PMID: 19346783 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309363</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309363</guid>        </item>
        <item>
            <title>[The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2309360&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346784%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Transient elastography is a useful method for diagnosing cirrhosis in patients with alcoholic liver disease.
    PMID: 19346784 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309360</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309360</guid>        </item>
        <item>
            <title>[Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2309358&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346785%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Our data suggest that the adefovir-monotherapy-induced virologic response is not durable in most patients with LAMV-R HBeAg-positive CHB, especially in those with a high pretreatment HBV DNA level.
    PMID: 19346785 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309358</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309358</guid>        </item>
        <item>
            <title>[The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2309356&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346786%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results of our study suggest that RBP4 is a serologic marker for disease severity in patients with CLD. It could also be useful as an early marker of CLD and of the relative success of antiviral therapy.
    PMID: 19346786 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309356</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309356</guid>        </item>
        <item>
            <title>[Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=2309354&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346787%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Reappearance of HCV RNA after earlier achievement of an SVR might appear more frequently than previously reported. Close follow-up of these patients is recommended and the implication of temporary viremia should be determined in the future.
    PMID: 19346787 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309354</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309354</guid>        </item>
        <item>
            <title>[A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2309352&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346788%26dopt%3DAbstract</link>
            <description>We report here a case of HCC that directly invaded the gallbladder, and that resembled gallbladder carcinoma invading the liver.
    PMID: 19346788 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309352</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309352</guid>        </item>
        <item>
            <title>[A case of rhabdomyolysis during hospitalization for acute hepatitis A.]</title>
            <link>http://www.medworm.com/index.php?rid=2309350&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346789%26dopt%3DAbstract</link>
            <description>We report a case of acute hepatitis A complicated by rhabdomyolysis during hospitalization.
    PMID: 19346789 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309350</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309350</guid>        </item>
        <item>
            <title>[A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy.]</title>
            <link>http://www.medworm.com/index.php?rid=2309348&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346790%26dopt%3DAbstract</link>
            <description>We report here a case of advanced HCC with portal vein tumor thrombosis that was effectively treated with percutaneous ethanol injection (PEI), having previously enabled subsequent successive transarterial chemoembolization (TACE). A 60-year-old male patient was diagnosed with a huge HCC, based on computed tomography and angiographic findings. Despite two sessions of TACE, the tumor invaded the right portal vein. PEI was performed on the malignant portal vein thrombosis, and three sessions thereof reduced the extent of tumor thrombi in the portal vein. Successive TACEs were performed to treat the HCC in the hepatic parenchyma. The patient was still living 19 months after the first PEI with no evidence of tumor recurrence, and his liver function remained well preserved.
    PMID: 19346790 [...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309348</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309348</guid>        </item>
        <item>
            <title>[Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue.]</title>
            <link>http://www.medworm.com/index.php?rid=2309346&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346791%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Park YN
    
    PMID: 19346791 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309346</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309346</guid>        </item>
        <item>
            <title>[Angiosarcoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2309344&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346792%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19346792 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309344</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309344</guid>        </item>
        <item>
            <title>Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=2309342&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346793%26dopt%3DAbstract</link>
            <description>Authors: Park NH
    
    PMID: 19346793 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309342</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309342</guid>        </item>
        <item>
            <title>[Treatment of chronic hepatitis C: efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients]</title>
            <link>http://www.medworm.com/index.php?rid=2309393&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119239%26dopt%3DAbstract</link>
            <description>Authors: Lee YJ
    
    PMID: 19119239 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309393</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309393</guid>        </item>
        <item>
            <title>[Hepatitis B virus genetic diversity and mutant]</title>
            <link>http://www.medworm.com/index.php?rid=2309391&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119240%26dopt%3DAbstract</link>
            <description>Authors: Yim HJ
    Hepatitis B virus (HBV) is a partially double stranded DNA virus with genetic diversity represented by eight genotypes (A to H). Natural course and response to treatment could be affected by HBV genotypes. HBV shows high rates of turn over in the absence of proof-reading ability. As a result, large amounts of quasispecies are produced naturally or antiviral-associated. HBV consists of four open reading frames, namely preS/S gene, precore/core gene, polymerase gene, and X gene. Mutations on preS gene can result in undetectable HBsAg even in case that HBV is replicating. Surface gene mutation leads to decreased binding affinity to anti-HBs, which is associated with a vaccine escape mutant. Precore mutation abolishes HBeAg whereas mutations on basal core promoter gene down...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309391</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309391</guid>        </item>
        <item>
            <title>[Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A]</title>
            <link>http://www.medworm.com/index.php?rid=2309388&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119242%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
    PMID: 19119242 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309388</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309388</guid>        </item>
        <item>
            <title>[Clinical characteristics of 159 cases of acute toxic hepatitis]</title>
            <link>http://www.medworm.com/index.php?rid=2309386&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119243%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The main cause of acute toxic hepatitis in the current study was the use of herbal medicines. The severity of liver injury at the time of admission was a major factor significantly associated with the hospitalization and recovery periods.
    PMID: 19119243 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309386</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309386</guid>        </item>
        <item>
            <title>[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: a comparative study]</title>
            <link>http://www.medworm.com/index.php?rid=2309383&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119244%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found no significant differences in therapeutic efficacies and adverse effects between the alpha-2a and -2b types of peginterferon as the initial treatment regimen in naive chronic hepatitis C patients.
    PMID: 19119244 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309383</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309383</guid>        </item>
        <item>
            <title>[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection]</title>
            <link>http://www.medworm.com/index.php?rid=2309381&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119245%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Although ADV monotherapy is effective, it leads to a high rate of mutations of HBV DNA reverse transcriptase gene in patients with chronic HBV infections who have LMV-resistant HBV mutants.
    PMID: 19119245 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309381</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309381</guid>        </item>
        <item>
            <title>[A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection]</title>
            <link>http://www.medworm.com/index.php?rid=2309379&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119246%26dopt%3DAbstract</link>
            <description>Authors: Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
    The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major concern in clinical practice for the treatment of hepatitis B virus (HBV). There is conflicting evidence on the outcome of pegylated interferon alpha (PEG-IFN alpha) therapy against lamivudine-resistant HBV, which is due to mutations in the YMDD motif. We experienced a patient with chronic hepatitis B who was successfully treated with PEG-IFN alpha-2a after the development of virologic and biochemical breakthrough during lamivudine therapy. Virologic breakthrough was associated with the emergence of YMDD mutants 48 months ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309379</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309379</guid>        </item>
        <item>
            <title>[Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation]</title>
            <link>http://www.medworm.com/index.php?rid=2309377&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119247%26dopt%3DAbstract</link>
            <description>We report the clinical course and antiviral response in a patient with FCH due to recurrent hepatitis C after cadaveric liver transplantation who was treated with pegylated interferon alpha-2a and ribavirin.
    PMID: 19119247 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309377</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309377</guid>        </item>
        <item>
            <title>[A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection]</title>
            <link>http://www.medworm.com/index.php?rid=2309375&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119248%26dopt%3DAbstract</link>
            <description>We report a case of a 64-year old woman who underwent hepatic resection due to epithelioid hemangioendothelioma in the right lobe that progressed to extrahepatic metastases of the bone, pleura, and peritoneum 22 months later. However, after resection there was no primary hepatic recurrence.
    PMID: 19119248 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309375</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309375</guid>        </item>
        <item>
            <title>[Mucin hypersecreting cholangiocarcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=2309373&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119249%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    
    PMID: 19119249 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309373</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309373</guid>        </item>
        <item>
            <title>[Focal nodular hyperplasia-like nodule]</title>
            <link>http://www.medworm.com/index.php?rid=2309371&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119250%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19119250 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309371</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309371</guid>        </item>
        <item>
            <title>[Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2077424&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119239%26dopt%3DAbstract</link>
            <description>Authors: Lee YJ
    
    PMID: 19119239 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077424</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077424</guid>        </item>
        <item>
            <title>[Hepatitis B virus genetic diversity and mutant.]</title>
            <link>http://www.medworm.com/index.php?rid=2077423&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119240%26dopt%3DAbstract</link>
            <description>Authors: Yim HJ
    Hepatitis B virus (HBV) is a partially double stranded DNA virus with genetic diversity represented by eight genotypes (A to H). Natural course and response to treatment could be affected by HBV genotypes. HBV shows high rates of turn over in the absence of proof-reading ability. As a result, large amounts of quasispecies are produced naturally or antiviral-associated. HBV consists of four open reading frames, namely preS/S gene, precore/core gene, polymerase gene, and X gene. Mutations on preS gene can result in undetectable HBsAg even in case that HBV is replicating. Surface gene mutation leads to decreased binding affinity to anti-HBs, which is associated with a vaccine escape mutant. Precore mutation abolishes HBeAg whereas mutations on basal core promoter gene down...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077423</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077423</guid>        </item>
        <item>
            <title>Changes in liver stiffness during the course of acute hepatitis A.</title>
            <link>http://www.medworm.com/index.php?rid=2077422&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119241%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Severe hepatic inflammation can affect the LS findings and thus, care is required when assessing fibrosis stage using LS measurement in patients with severe inflammation.
    PMID: 19119241 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077422</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077422</guid>        </item>
        <item>
            <title>[Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A.]</title>
            <link>http://www.medworm.com/index.php?rid=2077421&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119242%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
    PMID: 19119242 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077421</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077421</guid>        </item>
        <item>
            <title>[Clinical characteristics of 159 cases of acute toxic hepatitis.]</title>
            <link>http://www.medworm.com/index.php?rid=2077420&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119243%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The main cause of acute toxic hepatitis in the current study was the use of herbal medicines. The severity of liver injury at the time of admission was a major factor significantly associated with the hospitalization and recovery periods.
    PMID: 19119243 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077420</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077420</guid>        </item>
        <item>
            <title>[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study.]</title>
            <link>http://www.medworm.com/index.php?rid=2077419&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119244%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found no significant differences in therapeutic efficacies and adverse effects between the alpha-2a and -2b types of peginterferon as the initial treatment regimen in naive chronic hepatitis C patients.
    PMID: 19119244 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077419</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077419</guid>        </item>
        <item>
            <title>[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2077418&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119245%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Although ADV monotherapy is effective, it leads to a high rate of mutations of HBV DNA reverse transcriptase gene in patients with chronic HBV infections who have LMV-resistant HBV mutants.
    PMID: 19119245 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077418</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077418</guid>        </item>
        <item>
            <title>[A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2077417&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119246%26dopt%3DAbstract</link>
            <description>Authors: Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
    The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major concern in clinical practice for the treatment of hepatitis B virus (HBV). There is conflicting evidence on the outcome of pegylated interferon alpha (PEG-IFN alpha) therapy against lamivudine-resistant HBV, which is due to mutations in the YMDD motif. We experienced a patient with chronic hepatitis B who was successfully treated with PEG-IFN alpha-2a after the development of virologic and biochemical breakthrough during lamivudine therapy. Virologic breakthrough was associated with the emergence of YMDD mutants 48 months ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077417</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077417</guid>        </item>
    </channel>
</rss>

